We recently discovered that human neutrophils express immuno-active and microbicidal glycoproteins carrying unusual and highly truncated paucimannosidic N-glycans (Man1-3GlcNAc2Fuc0-1), but their biosynthesis remains elusive. Guided by the well-characterised truncation pathway in invertebrates and plants in which the N-acetyl-β-D-hexosaminidase (Hex) isoenzymes catalyse paucimannosidic protein formation, we here set out to test if homologous human Hex isoenzymes encoded by HEXA and HEXB drive a similar truncation pathway in human neutrophils [1]. To this end, we firstly performed quantitative glycomics and glycoproteomics of several CRISPR-Cas9-edited Hex-disrupted neutrophil-like HL-60 mutants (HEXA-KO and HEXB-KO) and matching unedited cell lines. Hex disruption was validated using next-generation sequencing, ELISA, proteomics and Hex enzyme activity assays. Excitingly, all Hex-disrupted mutants displayed significantly reduced levels of paucimannosylation, particularly of Man2-3GlcNAc2Fuc1, relative to unedited HL-60 suggesting that both HEXA and HEXB contribute to paucimannosidic protein formation via a hitherto unexplored truncation pathway in human neutrophils. Quantitative N-glycomics indeed demonstrated reduced utilisation of a putative non-canonical truncation pathway in favour of the canonical elongation pathway in all Hex-disrupted HL-60 mutants relative to unedited controls. Quantitative glycoproteomics recapitulated the truncation-to-elongation switch in all Hex-disrupted HL-60 mutants and showed a pronounced switch for N-glycoproteins co-trafficking with Hex to the azurophilic granules of neutrophils such as myeloperoxidase. To support the Hex-paucimannose link, we then documented that neutrophils isolated from an early-onset Sandhoff disease patient (HEXB-/-) display dramatically reduced paucimannosylation relative to neutrophils from an age-matched unaffected donor. We conclude that both human Hex α and β mediate the formation of immuno-active and antimicrobial paucimannosidic proteins via a putative non-canonical truncation pathway in neutrophils.